Page 34 - Mobile Opera News Today

Children who consumed a vegetarian diet showed similar growth and nutritional measures compared with their meat-eating peers but were more likely to be underweight, according to a study.

Topline findings from the phase 3 DELIVER trial show dapagliflozin significantly reduced risk for CV death or worsening HF compared with placebo in adults HF with mildly reduced or preserved ejection fraction, AstraZeneca announced.The trial of the SGLT2 inhibitor dapagliflozin (Farxiga) was conducted in more than 6,000 patients with HF with mildly reduced or preserved EF, defined as left

Different age-specific patterns defined the relationships between early daycare, severe airway infection, preterm birth and atopy-related diseases in childhood, according to a study published in Pediatric Allergy and Immunology. These differences could be used to help identify strategies to prevent or delay atopic diseases, Tadao Nagasaki, of the department of respiratory medicine at the Graduate

The FDA granted breakthrough device designation and permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer’s disease. Developed by Fujirebio Diagnostics, the Lumipulse G β-Amyloid Ratio test is intended for adults, aged 55 years and older, presenting with cognitive impairment who are being evaluated for AD and other

Xcardia Innovation Ltd., following the February FDA 510(k) clearance of its device for cardiac pacemaker and defibrillator lead extraction, announced the first-in-human use of the new device. According to a company press release, the new device (Xtractor) is designed with advanced controls, incorporating motor-assisted activation, steering capability, pedal activation and an advanced tip

The FDA cleared a new electrophysiology recording technology designed to improve signal acquisition and accuracy of electrogram interpretation in the diagnosis and treatment of complex atrial arrythmias, CathVision announced.The ECGenius EP Recording System includes EP recording technology and a proprietary hardware amplifier to acquire high-fidelity, low-noise, cardiac electrograms to help

Through 12 months, psilocybin-assisted treatment showed to be safe and effective for major depressive disorder, researchers reported in the Journal of Psychopharmacology. Natalie Gukasyan, MD, assistant professor of psychiatry and behavioral sciences at Johns Hopkins University in Baltimore, and colleagues conducted a randomized, waiting-list controlled study of 24 patients between the

A large observational cohort study conducted in Copenhagen confirmed that malabsorption is associated with celiac disease, according to researchers. The findings were published in Scientific Reports.

Rates for 10-year mortality and hospitalization for recurrence after an acute MI decreased steadily over more than 2 decades, though researchers observed marked inequities among subgroups. In an analysis assessing 25 years of Medicare data, researchers also observed marked differences in outcomes and temporal trends across demographic subgroups in the 30 days after an acute MI, emphasizing the

TecTraum Inc. announced complete enrollment status for a clinical trial evaluating its pro2cool device, a noninvasive hypothermic therapy system for treating concussions. The device, designed to decrease the severity of concussion symptoms, provides localized cooling for the head and neck to lower blood temperature before reaching the brain, the company stated in a press release.